Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
DelMar Pharmaceuticals Inc.
DMPI
Healthcare
Biotechnology
"DelMar Pharmaceuticals Inc is a clinical and commercial stage drug development company, which focuses on the research and development of drugs for the treatment of cancer. The company's principal product candidate includes VAL-083, a small-molecule chemotherapeutic agent, which is in clinical trials stage for the treatment of refractory glioblastoma multiforme, a form of brain cancer. DelMar...
also has a strategic collaboration with Guangxi Wuzhou Pharmaceutical for the development of VAL-083 use
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:DMPI)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(40)
•••
TAATInvestor
X
View Profile
View Bullboard History
Post by
TAATInvestor
on Jun 25, 2024 10:56am
holding 200k shares here! 5-8 USD after merger
STRONG BUY
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Jun 03, 2024 9:16am
RE:KTRA.....Positive NR this a.m...Phase 1 ; )
The SH Cops removed my last post because I tell the truth ....LoL....Here is what I said (edited to comply with SH Cops ; ) I will expand my reason.....I tend to think that this has churned enough
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jun 03, 2024 8:46am
KTRA.....Positive NR this a.m...Phase 1 ; )
Meeting up-coming 06/20/24.....I smell a rat but.... I figure it's worth a Lotto ticket here at 35 cents pre-market C what happen during Regular hour opening Good luck
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 11, 2024 1:00pm
New Press Release - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, CTLT, SCX, KTRA
NEW YORK , April 11, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:Codorus Valley Bancorp, Inc. (NASDAQ: CVLY)'s...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 10, 2024 9:18am
New Press Release - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MODN, KTRA
NEW YORK, NY / ACCESSWIRE / April 10, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:Model N, Inc. (NYSE:MODN)'s sale to Vista...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 09, 2024 8:15pm
New Press Release - STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Kintara Biopharma, Inc. - KTRA
NEW YORK, April 9, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 08, 2024 11:58pm
New Press Release - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MODN, SCX, KTRA
NEW YORK, April 8, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:Model N, Inc. (NYSE: MODN)'s sale to Vista Equity...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 06, 2024 9:51am
New Press Release - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PIK, CHX, KTRA
NEW YORK, NY / ACCESSWIRE / April 6, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:Kidpik Corp. (NASDAQ: PIK)'s merger with Nina...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 05, 2024 8:41pm
New Press Release - Lifshitz Law PLLC Announces Investigations of KTRA, CHX, PIK, and LABP
NEW YORK, NY / ACCESSWIRE / April 5, 2024 /Kintara Therapeutics, Inc. (NASDAQ:KTRA)Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of KTRA to TuHURA Biosciences, Inc.If you are a KTRA investor, and would like additional...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 05, 2024 1:31pm
New Press Release - KINTARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Kintara Therapeutics, Inc. - KTRA
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Kintara Therapeutics, Inc. (the “Company”) (NasdaqCM: KTRA) and TuHURA Biosciences, Inc. KSF is seeking to determine whether the merger and...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 05, 2024 1:10pm
New Press Release - Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm
NEW YORK, April 5, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies. Kuehn Law is...
read article.
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 05, 2024 12:33pm
KTRA...Say Good-bye to Hollywood.....
say good-bye my Baby ! Sub 12 cents and this is sub 10 in a heartbeat
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Apr 05, 2024 12:04pm
RE:KTRA....All the TA DT'ers are watching for.....
What did I tell you?
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 05, 2024 10:29am
KTRA....All the TA DT'ers are watching for.....
The Gap Fill over $0.13 cents....sorry ...ain't going to happen Don't waste ur time
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 04, 2024 9:44am
KTRA.....back to the woodshed for another whoopin
All the Chasers from yesterday are destroyed......again !
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >